Bayer Aktiengesellschaft

Bayer Healthcare Aktiengesellschaft

Aicuris Gmbh + Co. Kg.

Peter Eckenberg

Wolfgang Bender

Kerstin Henninger

Olaf Weber

Sabine Hallenberger

Hilmar Bischoff

Jörg Keldenich

Dirk Denzer

Ulrich Nielsch

Siegfried Goldmann

Ulrich E Muller

Siegfried Raddatz

Gunter Schmidt

Martin Hendrix

Udo Schneider

Tobias Wunberg

Joerg Keldenich

Judith Baumeister

Holger Zimmermann

Rudi Grutzmann

Gerald Kleymann

Ulrich Betz

Martin Radtke

Armin Kern

Jürgen Reefschläger

Michael H&auml;rter

Axel Jensen

Gabriele Handke

J&uuml;rgen Reefschl&auml;ger

J&ouml;rg Trappe

Franz Zumpe

Juergen Reefschlaeger

Stefan Wohlfeil

Rüdiger Fischer

Peter Kolkhof

J&ouml;rg Keldenich

Stefan Lohmer

Ulrich M&uuml;ller

Rudi Gr&uuml;tzmann

R&uuml;diger Fischer

The present invention relates to novel sulphonamides of the general formula (I) in which the substituents R, R, R, Rand A and X are as defined in claimand other claims, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.

Arylsulfonamides as antiviral agents

The invention relates to novel sulfonamides of general formula (I) where the substituents R, R, R, R, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.

Hetrocyclic aryl sulphonamides

The present invention relates to novel compounds, to a process for their preparation and to their use as medicaments, in particular as antiviral medicaments.

Thiazolyl amide derivatives

The present invention relates to thiazolylurea derivatives, a process for their preparation, and their use as pharmaceuticals, in particular as antiviral pharmaceuticals.

Thiazolyl urea derivatives and their utilization as antiviral agents

The present invention relates to novel compounds which are suitable as pharmaceuticals, to processes for their preparation and to their use as pharmaceuticals, in particular as antiviral agents.

Substituted indole sulfonamides as anitviral agents

Naphthyl-substituted and anilide-substituted sulfonamides

The new arylacetamides are obtained by first converting appropriately substituted arylacetic acids into the acetyl chlorides and then converting these into the amides using the appropriate amines. The new arylacetamides can be used as active compounds in medicaments, in particular in antiatherosclerotic medicaments.

Arylacetamides and their use as medicaments

The pyrimido[1,2-a]indoles according to the invention are prepared by reacting appropriately substituted phenylacetic acid derivatives with phenylglycinols. The pyrimido[1,2-a]indoles can be used as active compounds in medicaments, in particular in medicaments with antiatherosclerotic activity.

Pyrimido[1,2-a]indoles

Compounds of the formula (I): ##STR1## are prepared by reaction of the phenylacetic acid derivatives substituted by the appropriate heterocycles, optionally in an activated form, with phenylglycinols. The compounds are suitable as active compounds in medicaments, in particular in medicaments having antiatherosclerotic activity.

Pyridazino-, pyrimido-, pyrazino- and triazinoindoles,

Growing community of inventors

Wuppertal, Germany

Peter Eckenberg